Skip to content

Exelixis EXEL Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five

Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five at other companies

Incyte logo
IncyteINCY
Gilead Sciences logo
Gilead SciencesGILD
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
Moderna logo
ModernaMRNA

Other financials

Income statement

See full
Revenue$610.8M+10.0%
Gross profit$590.9M+10.2%
Operating income$251.3M+34.5%
Net income$210.5M+31.9%
EPS (diluted)$0.79+43.6%

Balance sheet

See full
Cash & equivalents$226.2M+23.1%
Total debt$169.5M-9.4%
Total equity$1.9B-9.2%
Total assets$2.6B-8.6%

Cash flow

See full
Operating cash flow$251.8M+19.1%
CapEx$1.5M-48.9%
Free cash flow$250.3M+20.1%

Valuation

See full
Market cap$13.05B+10.1%
Enterprise value$12.99B+9.5%
P/E15.7×-2.8×
P/S5.5×+0.3×

Profitability

See full
Gross margin96.4%-0.3pp
Operating margin39.4%+6.3pp
Net margin35.1%+7.1pp
FCF margin38.6%+2.9pp

Returns & leverage

See full
Return on equity41%+10.8pp
Debt / equity0.1×0.0×
Current ratio3.3×-0.2×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue.

The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Exelixis's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Exelixis's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five?
Exelixis (EXEL) reported debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five of $649.14M in Q1 2026.
How has Exelixis's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five changed year-over-year?
Exelixis's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five increased by 4.8% year-over-year, from $619.44M to $649.14M.
What is the long-term trend for Exelixis's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five?
Over 5 years (2020 to 2025), Exelixis's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five has grown at a 13.3% compound annual growth rate (CAGR), from $321.75M to $600.43M.